Blood test may help heart failure patients avoid hospital stays

NCT ID NCT04554277

Recruiting now Knowledge-focused Sponsor: University Hospital, Montpellier Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether monitoring a blood marker called sST-2 can help doctors adjust treatment for people with acute heart failure. The goal is to see if this approach reduces hospital readmissions and improves quality of life. Researchers will compare patients whose treatment is guided by sST-2 levels to those receiving usual care over 24 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: sST-2 biomarker monitoring
What this could lead to: If successful, this could show that using sST-2 levels to guide treatment reduces hospital readmissions and improves quality of life for heart failure patients.
What could go wrong: This is an early-stage study focused on cost-effectiveness, not a direct treatment. The biomarker may not reliably predict outcomes, and results may not apply to all heart failure patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

heart failure

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HEART FAILURE

Contacts and locations

Locations

APHP Pompidou
NOT_YET_RECRUITING

Paris, France
Arnaud de Villeneuve Hospital
RECRUITING

Montpellier, France
CH Béziers
RECRUITING

Béziers, France
CHU Angers
RECRUITING

Angers, France
CHU Besançon
RECRUITING

Besançon, France
CHU Caen
RECRUITING

Caen, France
CHU Grenoble
RECRUITING

Grenoble, France
CHU Nimes
RECRUITING

Nîmes, France
CHU Rennes
NOT_YET_RECRUITING

Rennes, France
CHU Toulouse
RECRUITING

Toulouse, France
CHU Vannes
RECRUITING

Vannes, France
Lapeyronie Hospital
ACTIVE_NOT_RECRUITING

Montpellier, Occitanie, 34295, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.